PHOENIX, April 11, 2006 (PRIMEZONE) -- Synovics Pharmaceuticals, Inc. (OTCBB:SYVC), a specialty pharmaceutical company with proprietary drug formulation and delivery technologies utilized in the development of an extensive pipeline of difficult to formulate, oral controlled-release generic and branded drugs, announced today that it completed the process of changing its name and is now trading under the symbol “SYVC” on the Bulletin Board. The Company also announced that it is changing its CUSIP number to 87163M 10 1. The Company previously announced that it had begun the process of changing its name from Bionutrics, Inc to Synovics Pharmaceuticals, Inc. by filing a Preliminary 14C with the SEC on Feb 3, 2006 and by filing a Definitive 14C on March 2, 2006.
